KALA BIO, INC. Other Current Assets
KALA BIO, INC. (KALA) had Other Current Assets of $477.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2019-03-12
- 2018-12-31: Other Assets, Current $477.00K.
- 2017-12-31: Other Assets, Current $196.00K.
- 2017-09-30: Other Assets, Current $158.00K.
- 2017-06-30: Other Assets, Current $176.00K.
| Period end | Other Assets, Current |
|---|---|
| 2018-12-31 | $477.00K 10-K · filed 2019-03-12 |
| 2017-12-31 | $196.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $158.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $176.00K 10-Q · filed 2017-08-31 |
| 2016-12-31 | $41.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |